Eversheds Sutherland has advised Peptonic

science laboratory test tubesscience laboratory test tubes

Eversheds Sutherland has advised Peptonic

June 26, 2024

Sweden
Sweden
Sweden
Eversheds Sutherland advised Peptonic Medical AB ("Peptonic") on its SEK 61.4 million rights issue of units. 
 
Peptonic is a biomedical company engaged in the research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to provide treatments for women's health and medical conditions. The company develops hormone-free products for the treatment of vaginal atrophy and vaginal dryness. The company has its headquarters in Sweden.
 
Eversheds Sutherland’s team consisted of Mark Falkner, John Edgren and Hanna Ullerholt. Mangold Fondkommission AB acted as financial advisor to Peptonic.
The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer.

Services

Industries

Key contacts

markfalkner@eversheds-sutherland.se

Mark Falkner

Partner

Stockholm, Sweden

johnedgren@eversheds-sutherland.se

John Edgren

Senior Associate

Stockholm, Sweden

hannaullerholt@eversheds-sutherland.se Headshot

Hanna Ullerholt

Associate

Stockholm, Sweden

Latest Insights

Latest News

Latest Events

shopping district

legal updates

May 29, 2026

Consumer Lens - Session 1 | The Rise of European Class Actions

Business meeting close up discussing data

podcasts and webcasts

May 29, 2026

Tax NOLs in Cross-Border Structures Webinar

Pay-Transparency-Waterdroplets-on-glass

legal updates

May 28, 2026

EU Pay Transparency Directive

Financial district skyscrapers glass high-rise buildings urban skyline

legal updates

May 27, 2026

Trade secrets and the Digital Omnibus: key risks and safeguards

© Eversheds Sutherland 2026. All rights reserved. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client. For further information about these Eversheds Sutherland Entities and Eversheds Sutherlands’ structure please see the Legal Notices page of this website.